Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00314288
Recruitment Status : Completed
First Posted : April 13, 2006
Last Update Posted : January 23, 2017
Information provided by:
EMD Serono

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : July 2003